Monographie - Telavancin hydrochloride - Stabilis 4.0

Zadnja posodobitev :
08/05/2024

Antibiotik

Telavancin hydrochloride

Brizgalka

Stabilnost raztopine

Stabilnost mešanice

Faktorji, ki vplivajo na stabilnost

Kompatibilnost

Način aplikacije

Viri

Pdf

Kemična formula

Lastniško ime

Lastniško ime

Sestava pomožnih snovi je med paralelami lahko različna

Vibativ

Kanada, Velika Britanija, Združene države Amerike

Viri

Brizgalka

Viri : Telavancin hydrochloride

	Tip	Objava
2006	časopis	Gu Z, Wong A, Raquinio E, Nguyen A. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. Hosp Pharm 2015 ; 50, 7: 609-614.
3254	časopis	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3260	Traduction Laboratorij	Telavancin (Vibativ®) - Summary of Products characteristics Astellas Pharma Europe 2011
3327	časopis	LaPlante K.L, Woodmansee S, Mermel L.A. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. Am J Health-Syst Pharm 2012 ; 69:1405-1409
3835	časopis	Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C. Chemical Stability of Telavancin in Elastomeric Pumps. Current Ther Res 2015 ; 77: 99-104.
3839	časopis	Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Current Ther Res 2015 ; 77: 105-110.

Mentions Légales